A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects.
about
The role of concentration-effect relationships in the assessment of QTc interval prolongationHead-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injuryDoes glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes?The DPP-4 inhibitor linagliptin does not prolong the QT interval at therapeutic and supratherapeutic doses.Effect of trabectedin on the QT interval in patients with advanced solid tumor malignanciesRandomized, Controlled, Thorough QT/QTc Study Shows Absence of QT Prolongation with Luseogliflozin in Healthy Japanese Subjects.Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up.Direct cardiovascular effects of glucagon like peptide-1.The cardiovascular safety of incretin-based therapies: a review of the evidence.Sitagliptin: a review of its use in patients with type 2 diabetes mellitus.The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes.Sitagliptin: A Review in Type 2 Diabetes.A supratherapeutic dose of the Janus kinase inhibitor tasocitinib (CP-690,550) does not prolong QTc interval in healthy participants.
P2860
Q26866417-6A5D844B-E382-4066-9288-78EC910701B1Q33826729-AA8E404B-5E18-4E69-BBD2-2A8FB03AA8ECQ34570576-C1243A29-19C0-420F-8522-E9A09C6D6884Q35120585-90A2F19C-938E-4D25-AE35-A9B79CC9A4F0Q35693620-A49B02F3-A3CD-4C54-A000-D41FCC163398Q36131466-1DBCA1A7-BFD9-4E5A-A356-A4E34926E88AQ36758314-D6DB6890-EFCE-4894-952B-E93B0FB74B9BQ38132470-DD0A6088-A801-448C-9D9D-519F8EA893EBQ38134902-61B2F452-6389-4FB8-BBCA-6290D663FE3FQ38177173-29AFF569-3C73-4DAD-9CCF-289BC80FDAA6Q38205588-0E01B86B-BF0F-45AC-94CB-27B8C263490BQ38828606-41262592-9284-4A8D-B3FE-B69A43737BA3Q39081543-A007774A-27BD-4BE2-960B-47C8E4353D23Q51528930-C5B64EE5-8498-440E-AE55-924CCFD465A3
P2860
A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A thorough QTc study to assess ...... arization in healthy subjects.
@ast
A thorough QTc study to assess ...... arization in healthy subjects.
@en
type
label
A thorough QTc study to assess ...... arization in healthy subjects.
@ast
A thorough QTc study to assess ...... arization in healthy subjects.
@en
prefLabel
A thorough QTc study to assess ...... arization in healthy subjects.
@ast
A thorough QTc study to assess ...... arization in healthy subjects.
@en
P2093
P2860
P356
P1476
A thorough QTc study to assess ...... arization in healthy subjects.
@en
P2093
Arthur J Bergman
Daniel M Bloomfield
David Hreniuk
Gary A Herman
John A Wagner
Jutta Miller
Kalyan Ghosh
Keith M Gottesdiener
Lisa Hickey
Maria J Gutierrez
P2860
P304
P356
10.1177/0091270009337511
P577
2009-08-01T00:00:00Z